MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/all.14278

Медицинская библиотека · Allergy · 2020

Transfer and loss of allergen-specific responses via stem cell transplantation: A prospective observational study.

Debiasi Markus, Pichler Herbert, Klinglmüller Florian, Boztug Heidrun, Schmidthaler Klara, Rech Jonas, Scherer David, Lupinek Christian, Valenta Rudolf, Kacinska-Pfaller Ewa, Geyeregger Rene, Fritsch Gerhard, Haas Oskar A, Peters Christina, Lion Thomas, Akdis Mübeccel, Matthes Susanne, Akdis Cezmi A, Szépfalusi Zsolt, Eiwegger Thomas

СтатьяНаблюдательное исследованиеПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND

Currently, no estimates can be made on the impact of hematopoietic stem cell transplantation on allergy transfer or cure of the disease. By using component-resolved diagnosis, we prospectively investigated 50 donor-recipient pairs undergoing allogeneic stem cell transplantation. This allowed calculating the rate of transfer or maintenance of allergen-specific responses in the context of stem cell transplantation.

METHODS

Allergen-specific IgE and IgG to 156 allergens was measured pretransplantation in 50 donors and recipients and at 6, 12 and 24 months in recipients post-transplantation by allergen microarray. Based on a mixed effects model, we determined risks of transfer of allergen-specific IgE or IgG responses 24 months post-transplantation.

RESULTS

After undergoing stem cell transplantation, 94% of allergen-specific IgE responses were lost. Two years post-transplantation, recipients' allergen-specific IgE was significantly linked to the pretransplantation donor or recipient status. The estimated risk to transfer and maintain individual IgE responses to allergens by stem cell transplantation was 1.7% and 2.3%, respectively. Allergen-specific IgG, which served as a surrogate marker of maintaining protective IgG responses, was highly associated with the donor's (31.6%) or the recipient's (28%) pretransplantation response.

CONCLUSION

Hematopoietic stem cell transplantation profoundly reduces allergen-specific IgE responses but also comes with a considerable risk to transfer allergen-specific immune responses. These findings facilitate clinical decision-making regarding allergic diseases in the context of hematopoietic stem cell transplantation. In addition, it provides prospective data to estimate the risk of transmitting allergen-specific responses via hematopoietic stem cell transplantation.

Для цитирования: Debiasi Markus, Pichler Herbert, Klinglmüller Florian, Boztug Heidrun, Schmidthaler Klara, Rech Jonas, Scherer David, Lupinek Christian, Valenta Rudolf, Kacinska-Pfaller Ewa, Geyeregger Rene, Fritsch Gerhard, Haas Oskar A, Peters Christina, Lion Thomas, Akdis Mübeccel, Matthes Susanne, Akdis Cezmi A, Szépfalusi Zsolt, Eiwegger Thomas. Transfer and loss of allergen-specific responses via stem cell transplantation: A prospective observational study.. Allergy. 2020. DOI: 10.1111/all.14278.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.